DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



21 Day Irritancy Test of Azelaic Acid Pre-foam Formulation

Information source: Bayer
ClinicalTrials.gov processed this data on August 20, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Healthy

Intervention: azelaic acid pre-foam formulation (Drug); Vehicle pre-foam formulation (Drug); Water (Drug); Sodium lauryl sulfate (Drug)

Phase: Phase 1

Status: Completed

Sponsored by: Bayer

Official(s) and/or principal investigator(s):
Bayer Study Director, Study Director, Affiliation: Bayer

Summary

The purpose of this study is to determine the irritancy potential of azelaic acid pre-foam formulation.

Clinical Details

Official title: A Randomized, Double-blind, Vehicle-controlled Phase 1 Dermal Safety Study Using a 21 Day Cumulative Irritant Patch Test Design to Evaluate the Local Tolerability of Azelaic Acid Pre-Foam Formulation in Healthy Volunteers

Study design: Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Basic Science

Primary outcome: irritancy rating scale

Detailed description: This is the standard patch test over 21 days of exposure of the test product,its vehicle and a positive as well as a negative control.

Eligibility

Minimum age: 18 Years. Maximum age: 65 Years. Gender(s): Both.

Criteria:

Inclusion Criteria:

- healthy volunteers

- male ore female subjects

- aged 18 - 65 years

- ability to understand and fulfill the study requirements

Exclusion Criteria:

- affected skin in designated test area

- pregnancy or lactation

- not willing to comply with study requirements

Locations and Contacts

Robert I. Cooper, MD, Fargo, North Dakota 58104, United States
Additional Information

Click here and search for drug information provided by the FDA.

Click here and search for information on any recalls, market or product safety alerts by the FDA which might have occurred with this product.

Starting date: September 2011
Last updated: February 27, 2014

Page last updated: August 20, 2015

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017